Q. When will this study start?
A. See the announcement.
Q. Has ACW enough funds to go it on its own?
A. Yes, for the studies already announced.
Q. What kind of partner?
A. Big pharma.
Q. What kind of arrangement?
A. Maybe licensing for a geographic region.
Hold, held
Ann: FDA agrees to six-month Phase 2b Alzheimers Disease Trial, page-10
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $76.57M | |||
| Open | High | Low | Value | Volume |
| 2.6¢ | 2.7¢ | 2.6¢ | $45.29K | 1.741M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 3920693 | 2.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.7¢ | 6272360 | 9 |
View Market Depth
| Last trade - 14.00pm 02/10/2024 (20 minute delay) ? |
| ACW (ASX) Chart |